Adar Poonawalla, the chief executive of Serum, said in January that the vaccine, named Corovax, was expected to be launched by June.
"It has been tested against African and UK variants of #COVID19 and has an overall efficacy of 89%," tweeted Poonawalla, whose Serum Institute is the world's largest manufacturer of vaccines.